GeneWerk GmbH provides highly sensitive platforms and bioinformatics to determine fusion sequences adjacent to known DNA or RNA fragments in minimal tissue samples down to the single cell level. Applications include clonality and safety of (viral) vectors in gene therapy, on-target specificity of designer nucleases, immune repertoire studies in T cells and B cells and next generation sequencing (NGS). GeneWerk’s unique worldwide experience in gene therapy studies, bioinformatics, NGS, and associated regulatory demands can help to build the solutions you need by individual consultation.